| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Section of Endocrine Neoplasia & Hormonal Disorders (H.M.K., K.E.F.) and the Department of Neurosurgery (I.E.M.), The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; and Medical Department M (Diabetes and Endocrinology) (A.F.), Aarhus Kommunehospital, Aarhus, DK-8000 Denmark
Several decades of basic and clinical research have demonstrated that there is an association between the insulin-like growth factors (IGFs) and neoplasia. We begin with a brief discussion of the function and regulation of expression of the IGFs, their receptors and the IGF-binding proteins (IGFBPs). A number of investigational interventional strategies targeting the GH or IGFs are then reviewed. Finally, we have assembled the available scientific knowledge about this relationship for each of the major tumor types. The tumors have been grouped together by organ system and for each of the major tumors, various key elements of the relationship between IGFs and tumor growth are discussed. Specifically these include the presence or absence of autocrine IGF-I and IGF-II production; presence or absence of IGF-I and IGF-II receptor expression; the expression and functions of the IGFBPs; in vitro and in vivo experiments involving therapeutic interventions; and available results from clinical trials evaluating the effect of GH/IGF axis down-regulation in various malignancies.
This article has been cited by other articles:
![]() |
F. Cappuzzo, G. Tallini, G. Finocchiaro, R. S. Wilson, C. Ligorio, L. Giordano, L. Toschi, M. Incarbone, R. Cavina, L. Terracciano, et al. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients Ann. Onc., September 18, 2009; (2009) mdp357v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Wang, W.-J. Yao, T.-T. Chang, S.-T. Wang, and P. Chou The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2054 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ludovini, G. Bellezza, L. Pistola, F. Bianconi, L. Di Carlo, A. Sidoni, A. Semeraro, R. Del Sordo, F. R. Tofanetti, M. G. Mameli, et al. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients Ann. Onc., May 1, 2009; 20(5): 842 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Beltran, P. Mitchell, Y.-A Chung, E. Cajulis, J. Lu, B. Belmontes, J. Ho, M. M. Tsai, M. Zhu, S. Vonderfecht, et al. AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells Mol. Cancer Ther., May 1, 2009; 8(5): 1095 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. SHEEN-CHEN, H. ZHANG, C.-C. HUANG, and R.-P. TANG Insulin-like Growth Factor-binding Protein-3 in Breast Cancer: Analysis with Tissue Microarray Anticancer Res, April 1, 2009; 29(4): 1131 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaulfuss, P. Burfeind, J. Gaedcke, and J.-G. Scharf Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis Mol. Cancer Ther., April 1, 2009; 8(4): 821 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Muhlbradt, E. Asatiani, E. Ortner, A. Wang, and E. P. Gelmann NKX3.1 Activates Expression of Insulin-like Growth Factor Binding Protein-3 to Mediate Insulin-like Growth Factor-I Signaling and Cell Proliferation Cancer Res., March 15, 2009; 69(6): 2615 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schayek, K. Haugk, S. Sun, L. D. True, S. R. Plymate, and H. Werner Tumor Suppressor BRCA1 Is Expressed in Prostate Cancer and Controls Insulin-like Growth Factor I Receptor (IGF-IR) Gene Transcription in an Androgen Receptor-Dependent Manner Clin. Cancer Res., March 1, 2009; 15(5): 1558 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Martinez-Iglesias, S. Garcia-Silva, S. P. Tenbaum, J. Regadera, F. Larcher, J. M. Paramio, B. Vennstrom, and A. Aranda Thyroid Hormone Receptor {beta}1 Acts as a Potent Suppressor of Tumor Invasiveness and Metastasis Cancer Res., January 15, 2009; 69(2): 501 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huang, A. Greer, W. Hurlburt, X. Han, R. Hafezi, G. M. Wittenberg, K. Reeves, J. Chen, D. Robinson, A. Li, et al. The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors Cancer Res., January 1, 2009; 69(1): 161 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. GIRI, A. GOMES, R. SENGUPTA, S. BANERJEE, J. NAUTIYAL, F. H. SARKAR, and A. P.N. MAJUMDAR Curcumin Synergizes the Growth Inhibitory Properties of Indian Toad (Bufo melanostictus Schneider) Skin-derived Factor (BM-ANF1) in HCT-116 Colon Cancer Cells Anticancer Res, January 1, 2009; 29(1): 395 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Fuchs, R. M. Goldberg, D. J. Sargent, J. A. Meyerhardt, B. M. Wolpin, E. M. Green, H. C. Pitot, and M. Pollak Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741 Clin. Cancer Res., December 15, 2008; 14(24): 8263 - 8269. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Higham and P. J. Trainer Growth hormone excess and the development of growth hormone receptor antagonists Exp Physiol, November 1, 2008; 93(11): 1157 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vrieling, M. A. Rookus, E. Kampman, J. M.G. Bonfrer, A. Bosma, A. Cats, J. van Doorn, C. M. Korse, B. J.M. Witteman, F. E. van Leeuwen, et al. No Effect of Red Clover-Derived Isoflavone Intervention on the Insulin-Like Growth Factor System in Women at Increased Risk of Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2585 - 2593. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fottner, S. Sattarova, K. Hoffmann, G. Spottl, and M. M Weber Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers {alpha}-fetoprotein and human chorionic gonadotropin Eur. J. Endocrinol., September 1, 2008; 159(3): 317 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lonn, N. Rothman, W. R. Shapiro, H. A. Fine, R. G. Selker, P. M. Black, J. S. Loeffler, A. A. Hutchinson, and P. D. Inskip Genetic variation in insulin-like growth factors and brain tumor risk Neuro-oncol, August 1, 2008; 10(4): 553 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cao, H. Lu, J. Feng, J. Shu, D. Zheng, and Y. Hou Lung Cancer Risk Associated with Thr495Pro Polymorphism of GHR in Chinese Population Jpn. J. Clin. Oncol., April 1, 2008; 38(4): 308 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Ryan and P. E. Goss The Emerging Role of the Insulin-Like Growth Factor Pathway as a Therapeutic Target in Cancer Oncologist, January 1, 2008; 13(1): 16 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. B de Groot, B. Rikhof, J. van Doorn, H. J G Bilo, M. A Alleman, A. H Honkoop, and W. T A van der Graaf Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases Endocr. Relat. Cancer, December 1, 2007; 14(4): 979 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C van der Pols, C. Bain, D. Gunnell, G. Davey Smith, C. Frobisher, and R. M Martin Childhood dairy intake and adult cancer risk: 65-y follow-up of the Boyd Orr cohort Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1722 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Siahpush, T. L. Vaughan, J. N. Lampe, R. Freeman, S. Lewis, R. D. Odze, P. L. Blount, K. Ayub, P. S. Rabinovitch, B. J. Reid, et al. Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2387 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Rarick, M. A. Pikosky, A. Grediagin, T. J. Smith, E. L. Glickman, J. A. Alemany, J. S. Staab, A. J. Young, and B. C. Nindl Energy flux, more so than energy balance, protein intake, or fitness level, influences insulin-like growth factor-I system responses during 7 days of increased physical activity J Appl Physiol, November 1, 2007; 103(5): 1613 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chi-Hang Li and R. Li RAV12 Accelerates the Desensitization of Akt/PKB Pathway of Insulin-like Growth Factor I Receptor Signaling in COLO205 Cancer Res., September 15, 2007; 67(18): 8856 - 8864. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Rowinsky, H. Youssoufian, J. R. Tonra, P. Solomon, D. Burtrum, and D. L. Ludwig IMC-A12, a Human IgG1 Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Clin. Cancer Res., September 15, 2007; 13(18): 5549s - 5555s. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Tworoger, I-M. Lee, J. E. Buring, M. N. Pollak, and S. E. Hankinson Insulin-like Growth Factors and Ovarian Cancer Risk: A Nested Case-Control Study in Three Cohorts Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1691 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Feng, I. U. Agoulnik, N. V. Bogatcheva, A. A. Kamat, B. Kwabi-Addo, R. Li, G. Ayala, M. M. Ittmann, and A. I. Agoulnik Relaxin Promotes Prostate Cancer Progression Clin. Cancer Res., March 15, 2007; 13(6): 1695 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H M Peeters, A. Lukanova, N. Allen, F. Berrino, T. Key, L. Dossus, S. Rinaldi, C. H van Gils, H B. Bueno-de-Mesquita, H. Boeing, et al. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr. Relat. Cancer, March 1, 2007; 14(1): 81 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vrieling, M. A. Rookus, E. Kampman, J. M. G. Bonfrer, C. M. Korse, J. van Doorn, J. W. Lampe, A. Cats, B. J. M. Witteman, F. E. van Leeuwen, et al. Isolated Isoflavones Do Not Affect the Circulating Insulin-Like Growth Factor System in Men at Increased Colorectal Cancer Risk J. Nutr., February 1, 2007; 137(2): 379 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yin, F. Vreeland, L. J. Schaaf, R. Millham, B. A. Duncan, and A. Sharma Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy Clin. Cancer Res., February 1, 2007; 13(3): 1000 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Power, S. K. Miller, and P. T. Alpert Promising New Causal Explanations for Obesity and Obesity-Related Diseases Biol Res Nurs, January 1, 2007; 8(3): 223 - 233. [Abstract] [PDF] |
||||
![]() |
J Riedemann and V M Macaulay IGF1R signalling and its inhibition Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S33 - S43. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ergun-Longmire, A. C. Mertens, P. Mitby, J. Qin, G. Heller, W. Shi, Y. Yasui, L. L. Robison, and C. A. Sklar Growth Hormone Treatment and Risk of Second Neoplasms in the Childhood Cancer Survivor J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3494 - 3498. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Chen, M. F Nielsen, A. Caumo, H. Vilstrup, J. S. Christiansen, and J. Frystyk Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. Eur. J. Endocrinol., August 1, 2006; 155(2): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, G. Chakravarty, S. Kim, Y. D. Yazici, M. N. Younes, S. A. Jasser, A. A. Santillan, C. D. Bucana, A. K. El-Naggar, and J. N. Myers Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) in an Orthotopic Nude Mouse Model of Anaplastic Thyroid Carcinoma Clin. Cancer Res., August 1, 2006; 12(15): 4755 - 4765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Parsons, H. B. Carter, A. W. Partin, B. G. Windham, E. J. Metter, L. Ferrucci, P. Landis, and E. A. Platz Metabolic Factors Associated with Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2562 - 2568. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cappuzzo, L. Toschi, G. Tallini, G. L. Ceresoli, I. Domenichini, S. Bartolini, G. Finocchiaro, E. Magrini, G. Metro, A. Cancellieri, et al. Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib Ann. Onc., July 1, 2006; 17(7): 1120 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Severi, H. A. Morris, R. J. MacInnis, D. R. English, W. D. Tilley, J. L. Hopper, P. Boyle, and G. G. Giles Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1137 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Rudd, E. L. Webb, A. Matakidou, G. S. Sellick, R. D. Williams, H. Bridle, T. Eisen, R. S. Houlston, and the GELCAPS Consortium Variants in the GH-IGF axis confer susceptibilityto lung cancer. Genome Res., June 1, 2006; 16(6): 693 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Spence, A. L. Shaffer, L. M. Staudt, S. Amde, S. Manney, C. Terry, K. Weisz, and P. Nissley Transformation of Late Passage Insulin-Like Growth Factor-I Receptor Null Mouse Embryo Fibroblasts by SV40 T Antigen. Cancer Res., April 15, 2006; 66(8): 4233 - 4239. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Gable, B. A. Maddux, C. Penaranda, M. Zavodovskaya, M. J. Campbell, M. Lobo, L. Robinson, S. Schow, J. A. Kerner, I. D. Goldfine, et al. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol. Cancer Ther., April 1, 2006; 5(4): 1079 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hopfner, V. Baradari, A. Huether, C. Schofl, and H. Scherubl The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours. Endocr. Relat. Cancer, March 1, 2006; 13(1): 135 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin, P. M. Ridker, N. Rifai, I-M. Lee, J. E. Manson, J. E. Buring, and S. M. Zhang A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in Women. Cancer Res., March 1, 2006; 66(5): 2869 - 2875. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Ayuk and M C Sheppard Growth hormone and its disorders Postgrad. Med. J., January 1, 2006; 82(963): 24 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Parodi Dairy Product Consumption and the Risk of Breast Cancer J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 556S - 568S. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Canzian, J. D. McKay, R. J. Cleveland, L. Dossus, C. Biessy, C. Boillot, S. Rinaldi, M. Llewellyn, V. Chajes, F. Clavel-Chapelon, et al. Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2316 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler Insulin Resistance, Apoptosis, and Colorectal Adenoma Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2076 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Quigley, A. M. Gill, B. J. Crowe, K. Robling, J. J. Chipman, S. R. Rose, J. L. Ross, F. G. Cassorla, A. M. Wolka, J. M. Wit, et al. Safety of Growth Hormone Treatment in Pediatric Patients with Idiopathic Short Stature J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5188 - 5196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Keller, A. V. Schally, K. Groot, G. L. Toller, A. Havt, F. Koster, P. Armatis, G. Halmos, M. Zarandi, J. L. Varga, et al. Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone PNAS, July 26, 2005; 102(30): 10628 - 10633. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Sonntag, C. S. Carter, Y. Ikeno, K. Ekenstedt, C. S. Carlson, R. F. Loeser, S. Chakrabarty, S. Lee, C. Bennett, R. Ingram, et al. Adult-Onset Growth Hormone and Insulin-Like Growth Factor I Deficiency Reduces Neoplastic Disease, Modifies Age-Related Pathology, and Increases Life Span Endocrinology, July 1, 2005; 146(7): 2920 - 2932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Engel, G. Keller, A. V. Schally, G. L. Toller, K. Groot, A. Havt, P. Armatis, M. Zarandi, J. L. Varga, and G. Halmos Inhibition of Growth of Experimental Human Endometrial Cancer by an Antagonist of Growth Hormone-Releasing Hormone J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3614 - 3621. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liao, Y. Hu, D. J. Herrick, and G. Brewer The RNA-binding Protein IMP-3 Is a Translational Activator of Insulin-like Growth Factor II Leader-3 mRNA during Proliferation of Human K562 Leukemia Cells J. Biol. Chem., May 6, 2005; 280(18): 18517 - 18524. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Diorio, M. Pollak, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, S. Berube, C. Morin, and J. Brisson Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1065 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Arturi, E. Ferretti, I. Presta, T. Mattei, A. Scipioni, D. Scarpelli, R. Bruno, L. Lacroix, E. Tosi, A. Gulino, et al. Regulation of Iodide Uptake and Sodium/Iodide Symporter Expression in the MCF-7 Human Breast Cancer Cell Line J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2321 - 2326. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Jee, H. Ohrr, J. W. Sull, J. E. Yun, M. Ji, and J. M. Samet Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women JAMA, January 12, 2005; 293(2): 194 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lukanova and R. Kaaks Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 98 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Voskuil, A. Vrieling, L. J. van't Veer, E. Kampman, and M. A. Rookus The Insulin-like Growth Factor System in Cancer Prevention: Potential of Dietary Intervention Strategies Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 195 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terzolo, G. Reimondo, M. Gasperi, R. Cozzi, R. Pivonello, G. Vitale, A. Scillitani, R. Attanasio, E. Cecconi, F. Daffara, et al. Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 84 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lynch, P. I. Vodyanik, D. Boettiger, and M. A. Guvakova Insulin-like Growth Factor I Controls Adhesion Strength Mediated by {alpha}5{beta}1 Integrins in Motile Carcinoma Cells Mol. Biol. Cell, January 1, 2005; 16(1): 51 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liao, M. Patel, Y. Hu, S. Charles, D. J. Herrick, and G. Brewer Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells J. Biol. Chem., November 19, 2004; 279(47): 48716 - 48724. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gronbaek, A. Flyvbjerg, L. Mellemkjaer, A. Tjonneland, J. Christensen, H. Toft Sorensen, and K. Overvad Serum Insulin-Like Growth Factors, Insulin-Like Growth Factor Binding Proteins, and Breast Cancer Risk in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1759 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Enger, J. M. Greif, J. Polikoff, and M. Press Body Weight Correlates With Mortality in Early-Stage Breast Cancer Arch Surg, September 1, 2004; 139(9): 954 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, B.-A. Bengtsson, T. Rosen, A. Oden, and G. Johannsson Malignant Disease and Cardiovascular Morbidity in Hypopituitary Adults with or without Growth Hormone Replacement Therapy J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3306 - 3312. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Muller, J. J. Kopchick, A. Flyvbjerg, and A. J. van der Lely Growth Hormone Receptor Antagonists J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1503 - 1511. [Full Text] [PDF] |
||||
![]() |
M. Neid, K. Datta, S. Stephan, I. Khanna, S. Pal, L. Shaw, M. White, and D. Mukhopadhyay Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells J. Biol. Chem., February 6, 2004; 279(6): 3941 - 3948. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Pan, K. C. Johnson, A.-M. Ugnat, S. W. Wen, and Y. Mao Association of Obesity and Cancer Risk in Canada Am. J. Epidemiol., February 1, 2004; 159(3): 259 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sandhu, J. M. Gibson, A. H. Heald, D. B. Dunger, and N. J. Wareham Association between Insulin-Like Growth Factor-I: Insulin-Like Growth Factor-Binding Protein-1 Ratio and Metabolic and Anthropometric Factors in Men and Women Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 166 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Kanashiro, A. V. Schally, K. Groot, P. Armatis, A. L. F. Bernardino, and J. L. Varga Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin PNAS, December 23, 2003; 100(26): 15836 - 15841. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Harper, A. T. Galecki, D. T. Burke, S. L. Pinkosky, and R. A. Miller Quantitative trait loci for insulin-like growth factor I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice Physiol Genomics, September 29, 2003; 15(1): 44 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mao, S. Pan, S. W. Wen, and K. C. Johnson Physical Activity and the Risk of Lung Cancer in Canada Am. J. Epidemiol., September 15, 2003; 158(6): 564 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Y. Nomura, G. N. Stemmermann, J. Lee, and M. N. Pollak Serum Insulin-like Growth Factor I and Subsequent Risk of Colorectal Cancer among Japanese-American Men Am. J. Epidemiol., September 1, 2003; 158(5): 424 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Maloney, J. L. McLaughlin, N. E. Dagdigian, L. M. Garrett, K. M. Connors, X.-M. Zhou, W. A. Blattler, T. Chittenden, and R. Singh An Anti-Insulin-like Growth Factor I Receptor Antibody That Is a Potent Inhibitor of Cancer Cell Proliferation Cancer Res., August 15, 2003; 63(16): 5073 - 5083. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Richiardi, J. Askling, F. Granath, and O. Akre Body Size at Birth and Adulthood and the Risk for Germ-cell Testicular Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 669 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Chen, T. Ledet, H. Orskov, N. Jessen, S. Lund, J. Whittaker, P. De Meyts, M. B. Larsen, J. S. Christiansen, and J. Frystyk A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1149 - E1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-e. Wang, J. Shou, S. Ross, H. Koeppen, F. J. de Sauvage, and W.-Q. Gao Inhibition of Epithelial Ductal Branching in the Prostate by Sonic Hedgehog Is Indirectly Mediated by Stromal Cells J. Biol. Chem., May 9, 2003; 278(20): 18506 - 18513. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-T. Phan, I. J. Lim, B. H. Bay, R. Qi, M. T. Longaker, S.-T. Lee, and H. Huynh Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro Am J Physiol Cell Physiol, April 1, 2003; 284(4): C860 - C869. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yakar and C. J. Rosen From Mouse to Man: Redefining the Role of Insulin-Like Growth Factor-I in the Acquisition of Bone Mass Experimental Biology and Medicine, March 1, 2003; 228(3): 245 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Burroughs, J. Oh, J. C. Barrett, and R. P. DiAugustine Phosphatidylinositol 3-Kinase and Mek1/2 Are Necessary for Insulin-Like Growth Factor-I-Induced Vascular Endothelial Growth Factor Synthesis in Prostate Epithelial Cells: A Role for Hypoxia-Inducible Factor-1? Mol. Cancer Res., February 1, 2003; 1(4): 312 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Krajcik, N. D. Borofsky, S. Massardo, and N. Orentreich Insulin-like Growth Factor I (IGF-I), IGF-binding Proteins, and Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1566 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chaum and H. Yang Transgenic Expression of IGF-1 Modifies the Proliferative Potential of Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3758 - 3764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Garrone, G. Radetti, M. Sidoti, M. Bozzola, F. Minuto, and A. Barreca Increased Insulin-Like Growth Factor (IGF)-II and IGF/IGF-Binding Protein Ratio in Prepubertal Constitutionally Tall Children J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5455 - 5460. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Hunt, P. Toniolo, A. Akhmedkhanov, A. Lukanova, H. Dechaud, S. Rinaldi, A. Zeleniuch-Jacquotte, R. E. Shore, E. Riboli, and R. Kaaks Insulin-like Growth Factor II and Colorectal Cancer Risk in Women Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 901 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu, F. Jin, X.-O. Shu, B. D. L. Li, Q. Dai, J.-R. Cheng, H. J. Berkel, and W. Zheng Insulin-like Growth Factors and Breast Cancer Risk in Chinese Women Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 705 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sandhu, D. B. Dunger, and E. L. Giovannucci Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal Cancer J Natl Cancer Inst, July 3, 2002; 94(13): 972 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Sklar, A. C. Mertens, P. Mitby, G. Occhiogrosso, J. Qin, G. Heller, Y. Yasui, and L. L. Robison Risk of Disease Recurrence and Second Neoplasms in Survivors of Childhood Cancer Treated with Growth Hormone: A Report from the Childhood Cancer Survivor Study J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3136 - 3141. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. O. Hellawell, G. D. H. Turner, D. R. Davies, R. Poulsom, S. F. Brewster, and V. M. Macaulay Expression of the Type 1 Insulin-like Growth Factor Receptor Is Up-Regulated in Primary Prostate Cancer and Commonly Persists in Metastatic Disease Cancer Res., May 1, 2002; 62(10): 2942 - 2950. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huynh, P. K. H. Chow, L. L. P. Ooi, and K.-C. Soo A Possible Role for Insulin-like Growth Factor-binding Protein-3 Autocrine/Paracrine Loops in Controlling Hepatocellular Carcinoma Cell Proliferation Cell Growth Differ., March 1, 2002; 13(3): 115 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hoelzer, N. Gokbuget, O. Ottmann, C.-H. Pui, M. V. Relling, F. R. Appelbaum, J. J.M. van Dongen, and T. Szczepanski Acute Lymphoblastic Leukemia Hematology, January 1, 2002; 2002(1): 162 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu, X. Zi, Y. Zhao, D. Mascarenhas, and M. Pollak Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin) J Natl Cancer Inst, December 19, 2001; 93(24): 1852 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Whittaker, A. V. Groth, D. C. Mynarcik, L. Pluzek, V. L. Gadsboll, and L. J. Whittaker Alanine Scanning Mutagenesis of a Type 1 Insulin-like Growth Factor Receptor Ligand Binding Site J. Biol. Chem., November 16, 2001; 276(47): 43980 - 43986. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Szepeshazi, A. V. Schally, P. Armatis, K. Groot, F. Hebert, A. Feil, J. L. Varga, and G. Halmos Antagonists of GHRH Decrease Production of GH and IGF-I in MXT Mouse Mammary Cancers and Inhibit Tumor Growth Endocrinology, October 1, 2001; 142(10): 4371 - 4378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Leng, K. S. Leeding, P. R. Gibson, and L. A. Bach Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo Carcinogenesis, October 1, 2001; 22(10): 1625 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kineman, L. T. Teixeira, G. V. Amargo, K. T. Coschigano, J. J. Kopchick, and L. A. Frohman The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling Endocrinology, September 1, 2001; 142(9): 3764 - 3773. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gicquel, X. Bertagna, V. Gaston, J. Coste, A. Louvel, E. Baudin, J. Bertherat, Y. Chapuis, J.-M. Duclos, M. Schlumberger, et al. Molecular Markers and Long-Term Recurrences in a Large Cohort of Patients with Sporadic Adrenocortical Tumors Cancer Res., September 1, 2001; 61(18): 6762 - 6767. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Chan, M. Pollak, and H. Huynh Inhibition of Insulin-like Growth Factor Signaling Pathways in Mammary Gland by Pure Antiestrogen ICI 182,780 Clin. Cancer Res., August 1, 2001; 7(8): 2545 - 2554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Reiss, X. Tu, G. Romano, F. Peruzzi, J. Y. Wang, and R. Baserga Intracellular Association of a Mutant Insulin-like Growth Factor Receptor with Endogenous Receptors Clin. Cancer Res., July 1, 2001; 7(7): 2134 - 2144. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |